Trends in public- and industry-funded uterine cancer clinical trials and disability-adjusted life years from 2007 to 2019 - 28/09/22
Doi : 10.1016/j.ajog.2022.06.016
Connor C. Wang, MD, Shannon K. Rush, MD
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine & Public Health, Madison, WI
Shitanshu Uppal, MD
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI
Laurel W. Rice, MD, Ryan J. Spencer, MD, MS 
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine & Public Health, 600 Highland Ave., H4/664, Madison, WI 53792
Le texte complet de cet article est disponible en PDF.
Plan
| The authors report no conflict of interest. |
|
| No funding was obtained for this work. |
|
| Institutional review board approval and informed consent were not applicable as human subjects were not involved. |
© 2022
Publié par Elsevier Masson SAS.
Vol 227 - N° 4
P. 666-668 - octobre 2022 Retour au numéro
Article précédent
- Assessment of SARS-CoV-2 serostatus and hypertensive disorders of pregnancy
- Jourdan E. Triebwasser, Miren B. Dhudasia, Sagori Mukhopadhyay, Dustin D. Flannery, Sigrid Gouma, Scott E. Hensley, Karen M. Puopolo
- Dyspareunia in Zoon’s vulvitis
- Hans Verstraelen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?